Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3473]

Best practice in precision medicine for prostate cancer

Dr Elena Castro, Dr Pasquale Rescigno, Prof Gert Attard and Dr Axel Heidenreich

Best practice in precision medicine for prostate cancer ( Dr Elena Castro, Dr Pasquale Rescigno, Prof Gert Attard and Dr Axel Heidenreich )

ctDNA test guides post-surgical immunotherapy for muscle-invasive bladder cancer

Dr Joaquim Bellmunt - Dana-Farber Cancer Institute, Boston, USA

ctDNA test guides post-surgical immunotherapy for muscle-invasive bladder cancer ( Dr Joaquim Bellmunt - Dana-Farber Cancer Institute, Boston, USA )

Visugromab plus nivolumab significantly increases pathologic response in muscle...

Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy

Visugromab plus nivolumab significantly increases pathologic response in muscle-invasive bladder cancer ( Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy )

Sacituzumab tirumotecan improves progression-free and overall survival in EGFR...

Dr Li Zhang - Sun Yat-sen University Cancer Center, Guangzhou, China

Sacituzumab tirumotecan improves progression-free and overall survival in EGFR-TKI resistant NSCLC ( Dr Li Zhang - Sun Yat-sen University Cancer Center, Guangzhou, China )

ESMO 2025: Latest in EGFR mutant NSCLC

Dr Alfredo Addeo, Prof Nicolas Girard, Dr Anna Minchom and Prof Pascale Tomasini

ESMO 2025: Latest in EGFR mutant NSCLC ( Dr Alfredo Addeo, Prof Nicolas Girard, Dr Anna Minchom and Prof Pascale Tomasini )

Zongertinib shows high response rates in first-line HER2-mutant advanced NSCLC

Prof Sanjay Popat - The Royal Marsden Hospital, London, UK

Zongertinib shows high response rates in first-line HER2-mutant advanced NSCLC ( Prof Sanjay Popat - The Royal Marsden Hospital, London, UK )

Sacituzumab govitecan improves PFS in first-line metastatic TNBC patients...

Dr Javier C Cortés - Hospital Ruber Internacional, Madrid Spain

Sacituzumab govitecan improves PFS in first-line metastatic TNBC patients unable to receive PD-(L)1 inhibitors ( Dr Javier C Cortés - Hospital Ruber Internacional, Madrid Spain )

177Lu-PSMA-617 in metastatic castration-resistant prostate cancer shows higher...

Dr Kim Nguyen Chi - BC Cancer, British Columbia, Canada

177Lu-PSMA-617 in metastatic castration-resistant prostate cancer shows higher PSA response with lower toxicity ( Dr Kim Nguyen Chi - BC Cancer, British Columbia, Canada )

Adjuvant pembrolizumab in resected merkel cell carcinoma shows improved distant...

Dr Janice Mehnert - NYU Langone Health, New York, USA

Adjuvant pembrolizumab in resected merkel cell carcinoma shows improved distant metastasis-free survival ( Dr Janice Mehnert - NYU Langone Health, New York, USA )

Trastuzumab deruxtecan demonstrates advance in treatment for HER2-positive...

Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA

Trastuzumab deruxtecan demonstrates advance in treatment for HER2-positive gastric cancer ( Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )

IO102-IO103 cancer vaccine plus pembrolizumab demonstrates PFS benefit in...

Dr Inge Marie Svane - Copenhagen University Hospital, Copenhagen Denmark

IO102-IO103 cancer vaccine plus pembrolizumab demonstrates PFS benefit in advanced melanoma ( Dr Inge Marie Svane - Copenhagen University Hospital, Copenhagen Denmark )

Zanzalintinib plus atezolizumab improves survival in refractory mCRC

Dr Anwaar Saeed - University of Pittsburgh, Pittsburgh, USA

$Zanzalintinib plus atezolizumab improves survival in refractory mCRC ( Dr Anwaar Saeed - University of Pittsburgh, Pittsburgh, USA )$

More from ecancer